A detailed history of Mgo One Seven LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mgo One Seven LLC holds 15,655 shares of LLY stock, worth $11.9 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
15,655
Previous 500 3031.0%
Holding current value
$11.9 Million
Previous $452,000 2968.36%
% of portfolio
0.61%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $1.48 Million - $1.85 Million
1,922 Added 14.0%
15,655 $13.9 Million
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $3.7 Million - $4.64 Million
5,106 Added 59.19%
13,733 $12.4 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $121,401 - $162,417
-205 Reduced 2.32%
8,627 $6.71 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $177,514 - $209,265
-338 Reduced 3.69%
8,832 $5.15 Million
Q3 2023

Nov 03, 2023

BUY
$434.7 - $599.3 $426,006 - $587,314
980 Added 11.97%
9,170 $4.93 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $104,871 - $140,225
299 Added 3.79%
8,190 $3.84 Million
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $330,510 - $388,168
1,064 Added 15.59%
7,891 $2.71 Million
Q4 2022

Jan 25, 2023

BUY
$321.55 - $374.67 $84,889 - $98,912
264 Added 4.02%
6,827 $0
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $472,589 - $538,564
-1,594 Reduced 19.54%
6,563 $2.44 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $212,392 - $249,379
-762 Reduced 8.54%
8,157 $2.65 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $31,213 - $38,790
-133 Reduced 1.47%
8,919 $2.55 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $338,624 - $420,234
1,506 Added 19.96%
9,052 $2.5 Million
Q3 2021

Nov 09, 2021

BUY
$221.6 - $272.71 $15,512 - $19,089
70 Added 0.94%
7,546 $1.92 Million
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $145,162 - $187,766
804 Added 12.05%
7,476 $1.72 Million
Q1 2021

Apr 29, 2021

SELL
$164.32 - $212.72 $206,221 - $266,963
-1,255 Reduced 15.83%
6,672 $1.25 Million
Q4 2020

Jan 22, 2021

SELL
$130.46 - $172.63 $84,146 - $111,346
-645 Reduced 7.52%
7,927 $1.34 Million
Q3 2020

Oct 30, 2020

SELL
$146.22 - $169.13 $174,879 - $202,279
-1,196 Reduced 12.24%
8,572 $1.27 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $222,501 - $267,777
-1,631 Reduced 14.31%
9,768 $1.6 Million
Q1 2020

Apr 17, 2020

SELL
$119.05 - $147.35 $110,716 - $137,035
-930 Reduced 7.54%
11,399 $1.58 Million
Q4 2019

Jan 16, 2020

SELL
$106.92 - $132.43 $149,260 - $184,872
-1,396 Reduced 10.17%
12,329 $1.62 Million
Q3 2019

Oct 10, 2019

BUY
$106.79 - $116.16 $14,096 - $15,333
132 Added 0.97%
13,725 $1.54 Million
Q2 2019

Jul 16, 2019

SELL
$110.79 - $129.32 $116,329 - $135,786
-1,050 Reduced 7.17%
13,593 $1.51 Million
Q1 2019

Apr 09, 2019

BUY
$111.31 - $131.02 $532,729 - $627,061
4,786 Added 48.55%
14,643 $1.9 Million
Q4 2018

Jan 24, 2019

SELL
$105.9 - $118.64 $26,051 - $29,185
-246 Reduced 2.43%
9,857 $1.14 Million
Q3 2018

Oct 09, 2018

BUY
$85.86 - $107.31 $118,658 - $148,302
1,382 Added 15.85%
10,103 $1.08 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $20,407 - $24,090
-275 Reduced 3.06%
8,721 $675,000
Q4 2017

Feb 16, 2018

BUY
$81.94 - $87.89 $737,132 - $790,658
8,996
8,996 $760,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $720B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.